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a  b  s  t  r  a  c  t
Most  transplant  centers  screen  kidney  transplant  recipients  for BK  virus  (BKV)  infection  using  molecular
techniques  for  the virus  load  determination.  However,  there  is  no  consensus  about  the  pre-analytical
methods  involved  in  the  viral  detection.  In this  study  BK  viral  load  was  compared  by  the  means  of two
urine  treatment  protocols  (pelleted  vs.  whole  urine)  and  two  commercial  DNA  extraction  kits  for  a  quan-
titative  PCR  (qPCR)  experiment.  Ten  patients  who  presented  decoy  cells  in  their  urine  sediment  wereeywords:
KV
iagnosis
idney transplantation
olyomavirus
eal-time polymerase chain reaction
selected  for  the  study.  Viral  load  was  considerable  higher  (>1.5  log)  for pelleted  urine,  in  comparison  to
whole urine  but  no  signiﬁcant  difference  was  observed  between  the  extraction  kits. PCR  inhibition  did
not  occur  by using  pelleted  urine.  In order  to increase  test  sensitivity  to detect  BK  viruria, pelleted  urine
should be the  preferred  urine  compartment  for qPCR  experiments.
© 2013 Elsevier B.V. Open access under the Elsevier OA license.The polyomavirus BK (BKV) has been regarded as one of the key
gents that can lead to loss of graft function in patients who  have
ndergone kidney transplantation. BKV is the leading infectious
ause of graft loss occurring in the ﬁrst 5 years after transplanta-
ion (Bechert et al., 2010). The prevalence of BKV reactivation after
idney transplantation varies from 1 to 10% and the allograft loss
ue to BKV range from 10% to more than 80% (Hirsch et al., 2005).
urrently, the gold standard for the diagnosis of BKV nephropa-
hy is kidney biopsy, however when a positive result is obtained
he kidney may  already have suffered irreversible injury. Molec-
lar biology may  allow early detection of BKV, in a time frame
n which clinicians can still alter the patient immunosuppression
egime, potentially avoiding the occurrence of late-stage renal dis-
ase (Bechert et al., 2010).
It is well known that BK viruria may  precede viremia and BKV
ephropathy by several weeks (Koukoulaki et al., 2009) and, there-
ore, the detection of BK in urine is of paramount importance
n transplant patients. However, there is no consensus about the
∗ Corresponding author at: Molecular Biology Laboratory, ISCMPA, Av Indepen-
encia 155, Hospital Dom Vicente Scherer, 8 andar, Porto Alegre 90035-075, Brazil.
el.: +55 51 99951614; fax: +55 51 32137491.
E-mail address: acpasqualotto@hotmail.com (A.C. Pasqualotto).
166-0934     ©   2013 Elsevier B.V. 
ttp://dx.doi.org/10.1016/j.jviromet.2012.12.006
Open access under the Elsevier OA license.pre-analytical methods involved in the viral detection. Further-
more, it is necessary to establish the ideal urine compartment
to be analyzed (i.e., whole urine versus a pelleted sam-
ple) (Behzadbehbahani et al., 1997; Si-Mohamed et al., 2006;
Mitterhofer et al., 2010; Anzivino et al., 2011; Pires et al., 2011).
In this study, two urine treatment protocols and two  commercial
extraction kits for the detection of BK viruria in kidney transplant
patients were compared.
Urine samples from 10 patients attending a referral transplant
center in Southern Brazil were used in this study. These samples
were selected based on the presence of decoy cells in urine sedi-
ment by bright ﬁeld microscopy. Samples were collected in sterile
ﬂasks without preservatives and shipped to the Molecular Biology
Laboratory where they were refrigerated at 4 ◦C until processed
for DNA extraction. DNA was extracted from urine samples on the
same day of sample collection by using two commercial kits: QIAmp
DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany) – from
now on referred to as kit 1; and QIAmp Viral RNA Mini Kit (QIAGEN,
Hilden, Germany) – kit 2. Kits for tissue have been used in the lit-
erature to extract BKV DNA from urine samples (Mitterhofer et al.,
2010; Anzivino et al., 2011), whilst kit 2 has been recommended by
the manufacturer for such purpose (QIAGEN, 2010). For each DNA
puriﬁcation kit, two urine preparations were tested: whole urine
and urine pellet of centrifuged sample.
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Table  1
BK urinary viral load (copies per ml  of urine) obtained by the means of two commercial DNA extraction kits and two urine compartments (n = 10).
Whole urine Urinary pellet p value
Kit 1 QIAmp DNeasy Blood and Tissue Kit (Qiagen) 1.299 × 1010 5.676 × 1011 0.003
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eKit  2 QIAmp Viral RNA Kit (Qiagen) 1.1
p  value 1.0
When whole urine was tested, the sample was  homogenized and
 volume of 140 l and 220 l were used as initial sample, as rec-
mmended by the manufacturer, respectively, for DNA extraction
its 1 and 2.
For pelleted urine, DNA extraction proceeded as follows. For kits
 and 2, 10 ml  of homogenized urine was transferred to a sterile fal-
on tube and centrifuged at 3500 rpm for 10 min. The supernatant
as discarded and a pellet of 140 l for kit 1 and 220 l for kit 2
as used as recommended by the manufacturer.
Extracted DNA samples were stored at −80 ◦C for later quan-
itative polymerase chain reaction (qPCR) testing. The CPE-DNA
nternal Control (Nanogen, Buttigliera Alta, Italy) was added in each
f the extracted DNA samples, as recommended by the manufac-
urer. The internal control was the human -globin gene, which
as ampliﬁed simultaneously with the target sequence.
BKV DNA detection was performed by qPCR using a commer-
ial kit (BKV Q-PCR Alert Ampliprobe, Nanogen, Buttigliera Alta,
taly) in a 7500 thermal cycler qPCR System (Applied Biosystems).
he following cycling steps were used: pre-holding stage 2 min  at
0 ◦C, initial denaturation at 95 ◦C for 10 min, followed by 45 cycles
f 95 ◦C for 1 min  and 60 ◦C for 1 min. The standard curve for this
uantitative ampliﬁcation assay was obtained using BKV Q-PCR
tandard (Nanogen, Buttigliera Alta, Italy), containing four known
oncentrations of BKV DNA (102–105 plasmid copies in 10-fold
ilution steps). Results were read by comparing the cycle threshold
Ct) from the unknown sample with the standard controls. In addi-
ion to the positive controls, in every run a negative BKV control as
ell an internal control was added to the reaction.
Descriptive statistics were used to summarize the data. Vari-
bles were treated with Wilcoxon test with an internal conﬁdence
f 95%. p values of ≤0.05 were considered statistically signiﬁcant
nd data analysis was performed using the SPSS 16 software (IBM).
he study was  approved by the Institutional Review Board (proto-
ol numbers 3531/11 and 915/12), and followed the guidelines and
egulatory standards for research involving human subjects of the
razilian National Health Council (Resolution CNS/196).
The number of copies of BKV DNA detected by qPCR varied
arkedly when the two urine compartments were compared. The
verage difference between pelleted urine and whole urine was
.64 log for kit 1 (p = 0.003), and 1.59 log for kit 2 (p = 0.002). There
as no signiﬁcant difference when comparing the same urine
ompartment between both commercial DNA extraction kits (mag-
itude of difference was 0.07 log [p = 1.000] for whole urine and
.12 log [p = 0.472] for urine pellet) – Table 1.
There is a general agreement that the presence of BKV DNA
hould be screened in kidney transplant patients, preferably using
uantitative molecular tests. Although the detection of BKV in the
lood may  better predict BKV nephropathy, many studies rec-
mmend performing BKV screening using urinary samples, since
iruria may  precede viremia by several weeks (Si-Mohamed et al.,
006; Koukoulaki et al., 2009). Even though different protocols have
een used in the literature to detect BKV DNA in the urine, no previ-
us investigation has evaluated variations in BK viral load according
o different DNA extraction methods and urine protocols. Differ-
nt extraction methods have been published which include DNA
xtraction from a volume of 1 ml  of urine (Anzivino et al., 2011),
erforming a concentration step before DNA extraction (Elfaitouri
t al., 2006), testing whole urine (Pang et al., 2007), and urinary010 4.285 ×1011 0.002
0.472
pellet (Pires et al., 2011). Furthermore, BKV DNA has been extracted
from the urine using different commercial kits, including Qiagen
QIAmp Blood and Tissue Kit (Anzivino et al., 2011), Qiagen QIAmp
DNA Mini Kit (Pang et al., 2007), Invitrogen PureLink Viral RNA/DNA
Kit (Pires et al., 2011), and Qiagen Viral RNA Mini kit (Elfaitouri
et al., 2006). In this study, it was  demonstrated that the choice of
the urinary compartment is very important because different urine
protocol showed distinct BK viral loads, whilst the use of different
DNA extraction kits had a minor inﬂuence in quantitative results.
This study showed that the urinary pellet presents a consider-
able higher BK viral load when compared with the urine that was
only homogenized. The magnitude of difference between pelleted
and whole urine was  greater than 1.5 log for both DNA extraction
kits. Therefore, the use of pelleted urine increases the sensitivity
of the method to detect BKV, which may  be of particular interest
for patients with a low BK viral load. These results are in accor-
dance with the ﬁndings by Drachenberg et al. (2001), who  showed
that BK virions were observed mainly in the cell interior. Therefore,
using urine pellet as primary material has the potential to detect
higher concentrations of BKV in the clinical sample. A potential dis-
advantage of pellets relies on the increased concentration of PCR
inhibitors, a problem that did not occur in this investigation.
One of the main limiting factors for this study was  the small
number of samples evaluated. Increasing the number of compar-
isons could potentially show a signiﬁcant variation between DNA
extraction kits, which is something that deserves additional inves-
tigation. Since only patients who  were known to have decoy cells in
the urine were included in the study the number of BKV copies was
very high. For such patients, the difference in BK viral load observed
between pelleted and whole urine may  have no clinical relevance,
which is probably not the case of patients with low BK viral loads.
In conclusion, this study has demonstrated that pre-analytical
variables such as the urine protocol chosen for DNA  extraction may
markedly inﬂuence BK viral load detected by qPCR. A standard-
ized method for processing samples for BKV detection is ultimately
required.
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